We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Phillips 66
PSX
$82.9B
| $17.5M | 0.08% |
221,207
-3,232
| -1% | -$260K |
|
302
Corning
GLW
$126B
| $17.2M | 0.08% |
636,796
-5,996
| -0.9% | -$160K |
|
303
Lam Research
LRCX
$382B
| $17.1M | 0.08% |
1,334,480
-1,203,010
| -47% | -$14.1M |
|
|
BCR
304
DELISTED
CR Bard Inc.
BCR
| $17.1M | 0.08% |
68,755
-1,871
| -3% | -$451K |
|
|
WBA
305
DELISTED
Walgreens Boots Alliance
WBA
| $16.2M | 0.08% |
195,495
+11,669
| +6% | +$979K |
|
306
Centene
CNC
$31.3B
| $16.1M | 0.08% |
451,418
+2,304
| +0.5% | +$77.1K |
|
307
FedEx
FDX
$74.5B
| $15.8M | 0.08% |
80,991
-8,797
| -10% | -$1.68M |
|
308
Cinemark Holdings
CNK
$3.82B
| $14.6M | 0.07% |
330,309
-609,741
| -65% | -$25.7M |
|
309
Quest Diagnostics
DGX
$25.1B
| $14.5M | 0.07% |
147,288
+916
| +0.6% | +$87.3K |
|
310
Vanguard Total Stock Market ETF
VTI
$654B
| $14.4M | 0.07% |
119,025
-5,058
| -4% | -$606K |
|
311
Gartner
IT
$9.41B
| $14.3M | 0.07% |
132,156
-8,080
| -6% | -$833K |
|
312
UGI
UGI
$8B
| $13.9M | 0.07% |
280,897
-3,516
| -1% | -$167K |
|
313
Broadcom
AVGO
$1.82T
| $13.8M | 0.07% |
630,570
-102,410
| -14% | -$2.11M |
|
314
Cardinal Health
CAH
$53.4B
| $13.7M | 0.07% |
168,511
+53,884
| +47% | +$4.24M |
|
315
Amazon
AMZN
$2.5T
| $13.7M | 0.07% |
308,660
+20,000
| +7% | +$834K |
|
316
TE Connectivity
TEL
$58.8B
| $13.6M | 0.07% |
182,590
+11,540
| +7% | +$849K |
|
317
Lear
LEA
$7.19B
| $13.6M | 0.07% |
96,101
+86,747
| +927% | +$12.3M |
|
318
Berkshire Hathaway Class A
BRK.A
$1.07T
| $13.5M | 0.06% |
54
-1
| -2% | -$251K |
|
319
Edwards Lifesciences
EW
$47.6B
| $13.4M | 0.06% |
428,466
+21,282
| +5% | +$666K |
|
320
GSK
GSK
$103B
| $13.3M | 0.06% |
253,082
-11,392
| -4% | -$578K |
|
321
Target
TGT
$62.1B
| $13.3M | 0.06% |
241,569
-61,359
| -20% | -$3.82M |
|
322
Hasbro
HAS
$12.6B
| $13.3M | 0.06% |
132,955
+89,950
| +209% | +$8.33M |
|
323
Enterprise Products Partners
EPD
$83.8B
| $13.2M | 0.06% |
478,419
+26,416
| +6% | +$738K |
|
324
Helmerich & Payne
HP
$3.53B
| $13.2M | 0.06% |
198,243
-72,760
| -27% | -$5.18M |
|
|
NVO
325
Novo Nordisk
NVO
$216B
| $13.2M | 0.06% |
767,794
+201,740
| +36% | +$3.51M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.